In reference to the earlier intimation dated 18.03.2024, Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Kimia Biosciences has informed that the Company has received the confirmation from its Registrar & Transfer Agent, Beetal Financial Computer Services, regarding the issuance of duplicate share certificates. The details of shareholders are enclosed. Pursuant to SEBI Circular No. SEBI/MIRSD/MIRSD_RTAMB/P/2022/8 dated January 25, 2022; a letter of confirmation will be issued to the securities holder/ claimant upon completion of necessary procedures regarding duplicate share certificates.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1693.15 |
| Dr. Reddys Lab | 1221.25 |
| Cipla | 1230.75 |
| Zydus Lifesciences | 939.20 |
| Lupin | 2326.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: